344 related articles for article (PubMed ID: 31322831)
21. Disease activity-based management of rheumatoid arthritis in Dutch daily clinical practice has improved over the past decade.
Spijk-de Jonge MJ; Weijers JM; Boerboom LWM; Huis AMP; Atsma F; Van Hulst LTC; van de Laar MAFJ; Hulscher MEJL; van Riel PLCM
Clin Rheumatol; 2020 Apr; 39(4):1131-1139. PubMed ID: 31997083
[TBL] [Abstract][Full Text] [Related]
22. Rheumatologist-patient communication about exercise and physical therapy in the management of rheumatoid arthritis.
Iversen MD; Fossel AH; Daltroy LH
Arthritis Care Res; 1999 Jun; 12(3):180-92. PubMed ID: 10513508
[TBL] [Abstract][Full Text] [Related]
23. Cluster-Randomized Trial of a Behavioral Intervention to Incorporate a Treat-to-Target Approach to Care of US Patients With Rheumatoid Arthritis.
Harrold LR; Reed GW; John A; Barr CJ; Soe K; Magner R; Saunders KC; Ruderman EM; Haselkorn T; Greenberg JD; Gibofsky A; Harrington JT; Kremer JM
Arthritis Care Res (Hoboken); 2018 Mar; 70(3):379-387. PubMed ID: 28544704
[TBL] [Abstract][Full Text] [Related]
24. Factors influencing clinician prescribing of disease-modifying anti-rheumatic drugs for inflammatory arthritis: A systematic review and thematic synthesis of qualitative studies.
Lalor AF; Brooker JE; Rozbroj T; Whittle SL; Hill CL; Rowett D; Buchbinder R; O'Connor DA
Semin Arthritis Rheum; 2022 Aug; 55():151988. PubMed ID: 35286905
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness of initial methotrexate-based treatment approaches in early rheumatoid arthritis: an elicitation of rheumatologists' beliefs.
Pokharel G; Deardon R; Johnson SR; Tomlinson G; Hull PM; Hazlewood GS
Rheumatology (Oxford); 2021 Aug; 60(8):3570-3578. PubMed ID: 33367919
[TBL] [Abstract][Full Text] [Related]
26. Patients' preferences and economic considerations play an important role in treatment decisions: a discrete choice experiment among rheumatologists.
Hifinger M; Hiligsmann M; Ramiro S; Severens JL; Fautrel B; Watson V; Boonen A
Rheumatology (Oxford); 2017 Jan; 56(1):68-76. PubMed ID: 28028156
[TBL] [Abstract][Full Text] [Related]
27. Perceptions of methotrexate use in rheumatoid arthritis by rheumatologists and their patients: an Australian survey study.
Nash P; Nicholls D
Int J Rheum Dis; 2013 Dec; 16(6):652-61. PubMed ID: 24382276
[TBL] [Abstract][Full Text] [Related]
28. Economic considerations and patients' preferences affect treatment selection for patients with rheumatoid arthritis: a discrete choice experiment among European rheumatologists.
Hifinger M; Hiligsmann M; Ramiro S; Watson V; Severens JL; Fautrel B; Uhlig T; van Vollenhoven R; Jacques P; Detert J; Canas da Silva J; Scirè CA; Berghea F; Carmona L; Péntek M; Keat A; Boonen A
Ann Rheum Dis; 2017 Jan; 76(1):126-132. PubMed ID: 27190098
[TBL] [Abstract][Full Text] [Related]
29. Rheumatologists' Views and Experiences in Managing Rheumatoid Arthritis in Elderly Patients: A Qualitative Study.
Nawrot J; Boonen A; Peeters R; Starmans M; van Onna M
J Rheumatol; 2018 May; 45(5):590-594. PubMed ID: 29449497
[TBL] [Abstract][Full Text] [Related]
30. 'The lesser of two evils…' - views of persons with rheumatoid arthritis on medication adherence: a qualitative study.
Brandstetter S; Hertig S; Loss J; Ehrenstein B; Apfelbacher C
Psychol Health; 2016 Jun; 31(6):675-92. PubMed ID: 26832226
[TBL] [Abstract][Full Text] [Related]
31. Belgian rheumatologists' perception on eligibility of RA patients for anti-TNF treatment matches more closely Dutch rather than Belgian reimbursement criteria.
Geens E; Geusens P; Vanhoof J; Berghs H; Praet J; Esselens G; Lens S; Dufour JP; Vandenberghe M; Van Mullem X; Westhovens R; Verschueren P
Rheumatology (Oxford); 2009 May; 48(5):546-50. PubMed ID: 19254920
[TBL] [Abstract][Full Text] [Related]
32. I do not want to suppress the natural process of inflammation: new insights on factors associated with non-adherence in rheumatoid arthritis.
Ritschl V; Lackner A; Boström C; Mosor E; Lehner M; Omara M; Ramos R; Studenic P; Smolen JS; Stamm TA
Arthritis Res Ther; 2018 Oct; 20(1):234. PubMed ID: 30340628
[TBL] [Abstract][Full Text] [Related]
33. Are Health Care Professionals' Implicit and Explicit Attitudes Toward Conventional Disease-Modifying Antirheumatic Drugs Associated With Those of Their Patients?
van Heuckelum M; Hebing RCF; Vandeberg L; Linn AJ; Flendrie M; Nurmohamed MT; van Dulmen S; van den Ende CHM; van den Bemt BJF
Arthritis Care Res (Hoboken); 2021 Mar; 73(3):364-373. PubMed ID: 32166901
[TBL] [Abstract][Full Text] [Related]
34. Modifications in Systemic Rheumatic Disease Medications: Patients' Perspectives During the Height of the COVID-19 Pandemic in New York City.
Mancuso CA; Duculan R; Jannat-Khah D; Barbhaiya M; Bass AR; Mandl LA; Mehta B
Arthritis Care Res (Hoboken); 2021 Jun; 73(6):909-917. PubMed ID: 33085850
[TBL] [Abstract][Full Text] [Related]
35. Do out-of-pocket costs affect medication adherence in adults with rheumatoid arthritis? A systematic review.
Heidari P; Cross W; Crawford K
Semin Arthritis Rheum; 2018 Aug; 48(1):12-21. PubMed ID: 29496225
[TBL] [Abstract][Full Text] [Related]
36. The gap between practice and guidelines in the choice of first-line disease modifying antirheumatic drug in early rheumatoid arthritis: results from the ESPOIR cohort.
Benhamou M; Rincheval N; Roy C; Foltz V; Rozenberg S; Sibilia J; Schaeverbeke T; Bourgeois P; Ravaud P; Fautrel B
J Rheumatol; 2009 May; 36(5):934-42. PubMed ID: 19286850
[TBL] [Abstract][Full Text] [Related]
37. Rheumatologists' guideline adherence in rheumatoid arthritis: a randomised controlled study on electronic decision support, education and feedback.
Lesuis N; van Vollenhoven RF; Akkermans RP; Verhoef LM; Hulscher ME; den Broeder AA
Clin Exp Rheumatol; 2018; 36(1):21-28. PubMed ID: 28598775
[TBL] [Abstract][Full Text] [Related]
38. Application of Recommendations Regarding the Use of Subcutaneous Tumor Necrosis Factor Inhibitors in Spondyloarthritis by Rheumatologists in Daily Practice.
Pereira-Gillion C; Marot M; Griffoul-Espitalier I; Andras L; Goupille P; Salliot C
J Rheumatol; 2018 Apr; 45(4):491-497. PubMed ID: 29419472
[TBL] [Abstract][Full Text] [Related]
39. Perception of Originator Biologics and Biosimilars: A Survey Among Belgian Rheumatoid Arthritis Patients and Rheumatologists.
van Overbeeke E; De Beleyr B; de Hoon J; Westhovens R; Huys I
BioDrugs; 2017 Oct; 31(5):447-459. PubMed ID: 28929342
[TBL] [Abstract][Full Text] [Related]
40. Barriers to accessing biologic treatment for rheumatoid arthritis in Greece: the unseen impact of the fiscal crisis--the Health Outcomes Patient Environment (HOPE) study.
Souliotis K; Papageorgiou M; Politi A; Ioakeimidis D; Sidiropoulos P
Rheumatol Int; 2014 Jan; 34(1):25-33. PubMed ID: 24057144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
